I understand it better than you do because I can see the reduced risk of dilution due to the fact that the stock price is currently ten times higher than the 1¢ price that the company specified as the maximum in its' example of the risk of dilution.
You don't see the reduced risk of dilution at a 10¢ price or higher, so you don't see that the dilution disadvantages are now outweighed by the reduced risk of that dilution.
Now that there is a sharply-reduced risk of dilution, the question remains. Why hasn't Kevin sent the SEC some of the missing 10-Ks, 10-Qs, 8-Ks, and Form 4s? The most likely answer is that the company doesn't have good financial results and so the information in these forms will be bearish, and thus, it would drive down the stock price.
Funny how one acknowledges that GERS isn’t a normal company, but still has a hard time accepting that as a fact and keeps comparing a OTC pink sheet to DJ or Nasdaq companies